Thrombosis

Latest Features

Latest News

Preventing Venous Thromboembolism After Hip, Knee Arthoplasty: Comparing Anticoagulant Efficacy

Preventing Venous Thromboembolism After Hip, Knee Arthoplasty: Comparing Anticoagulant Efficacy

Fondaparinux and rivaroxaban have higher efficacy of reducing venous thromboembolism after total hip or knee arthroplasty, but also an increased risk of major bleeding.

CV Events Reduced in SLE With Aspirin and Hydroxychloroquine

CV Events Reduced in SLE With Aspirin and Hydroxychloroquine

Hydroxychloroquine in combination with low-dose asprin was protective against thrombosis in SLE.

Venous Thromboembolism Reduced in Orthopedic Surgery With Rivaroxaban

Venous Thromboembolism Reduced in Orthopedic Surgery With Rivaroxaban

Patients who received 10 mg of rivaroxaban daily had decreased the rate of venous thromboembolism by 33%.

Effect of Obesity Paradox on Venous Thromboembolism Risk in Atrial Fib

Effect of Obesity Paradox on Venous Thromboembolism Risk in Atrial Fib

A meta-analysis was conducted to examine concerns surrounding direct oral anticoagulant therapy in patients with extreme high or low body weight.

Right Upper Extremity Deep Vein Thrombosis: A Case Study

Right Upper Extremity Deep Vein Thrombosis: A Case Study

A case study of a patient presented to the emergency room for right upper extremity deep vein thrombosis after rib resection and subclavian vein stent placement 15 years ago.

Venous Thromboembolism and Sepsis Risks Increase With Short-Term Oral Corticosteriods

Venous Thromboembolism and Sepsis Risks Increase With Short-Term Oral Corticosteriods

An increased risk of sepsis, venous thromboembolism and fracture was linked to short term use of oral corticosteroids.

Effect of Warfarin Dose on Patients With HIV And DVT

Effect of Warfarin Dose on Patients With HIV And DVT

Study results were contrary to investigators' hypothesis regarding warfarin dosing in patients with and without HIV.

VTE Recurrence Risk Reduced With Rivaroxaban: Q&A With EINSTEIN CHOICE Investigator

VTE Recurrence Risk Reduced With Rivaroxaban: Q&A With EINSTEIN CHOICE Investigator

Results from the EINSTEIN CHOICE trial plus an interview with investigator Philip Stephen Wells, MD, FRCP(C), MSc.

Surgical Pulmonary Embolectomy Outcomes Not Affected by Thrombus Location

Surgical Pulmonary Embolectomy Outcomes Not Affected by Thrombus Location

Survival rates were high for patients with both central and peripheral pulmonary emboli.

Intracerebral Hemorrhage: Trends in Medical Complications

Intracerebral Hemorrhage: Trends in Medical Complications

After intracerebral hemorrhage, both acute renal failure and deep venous thrombosis have increased.

Sign Up for Free e-Newsletters